An Observational Study of Cardiac Events in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
An Observational Study of Cardiac Events in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
This is a single cohort observational safety study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study. Data will be collected from centre's medical records for up to 5 years or death.
Inclusion Criteria:
Exclusion Criteria:
Sankt Veit an der Glan, 9300, Austria
Vienna, 1090, Austria
Bielefeld, 33604, Germany
Dresden, 01127, Germany
Frankfurt am Main, 60389, Germany
Georgsmarienhütte, 49124, Germany
Hamburg, 22081, Germany
Hanover, 30625, Germany
Homburg/Saar, 66424, Germany
Jena, 07747, Germany
Lübeck, 23538, Germany
Mainz, 55131, Germany
Saint Wendel, 66606, Germany
Stade, 21680, Germany
Rionero in Vulture, Basilicate 85028, Italy
Naples, Campania 80131, Italy
Aviano, Friuli Venezia Giulia 33081, Italy
Trieste, Friuli Venezia Giulia 34100, Italy
Rome, Lazio 00135, Italy
Genoa, Liguria 16132, Italy
Pavia, Lombardy 27100, Italy
Candiolo, Piedmont 10060, Italy
Turin, Piedmont 10126, Italy
Navarra, Navarre 31008, Spain
San Cristóbal de La Laguna, Tenerife 38320, Spain
Jaén, 23007, Spain